GSK3B and breast cancer: stimulated TLR4 activation in human BC cell lines via LPS, triggering β‐catenin signaling through PI3K/Akt/GSK3β and promoting the transcription of downstream β‐linker protein target genes, ultimately leading to BC metastasis.